INDICAID® COVID-19 / Influenza A&B Antigen Test

FDA authorized 3-in-1 rapid POC test with exceptional accuracy, results in 15 minutes

FDA authorized
For in vitro use
For use with anterior nasal swab specimens

About

The COVID-19 / Influenza A&B Antigen Test is an innovative rapid test designed to qualitativley detect and differentiate influenza A and B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen.

Features

3:1: Detects COVID-19, Influenza A and Influenza B from a single nasal swab
Fast results: Delivers answers at just 15 minutes
Highly accurate: COVID-19 sensitivity: 92%, Influenza A sensitivity: 92.5%, and Influenza B sensitivity: 90.5%
Easy sampling: Utilizes a shallow nasa swab and suitable for individuals 2 and older

Specifications

Contents	Individually packaged test cassettes, buffer tubes and swabs, on-box tube holder, quick reference guide
Tests per kit	25
Specimen type	Anterior nasal swab
Time to result	15 minutes
Clinical Performance (vs RT-PCR)	Sensitivity (PPA) COVID-19: 92% \| FLU A: 92.5%. \| FLU B: 90.5% Specificity(NPA) COVID-19: 99% \| FLU A: 99.9%. \| FLU B: 99.9%
FDA Clearance	510(k)
Storage Condition	36º-86ºF (2º-30ºC); do not freeze; avoid direct sunlight
Shelf Life	24 Months

Intended Use

This test is intended for the detection of proteins from SARS-CoV-2, influenza A virus, and influenza B virus. Negative results do not preclude infection and should not be used as the sole basis for patient management decisions. Individuals should consult with a healthcare provider for further evaluation and care.